Recent postings in the WSJ blog and elsewhere have asked the troubling question: Does Lean Manufacturing, by definition, lead to quality control problems? Click here for an interesting read. (For something that doesn't require registration, click here.)

In its neverending fight against both poor manufacturing practices and the manufacture and marketing of unapproved drugs, FDA has filed a Consent Decree and expects courts to prohibit Activis’ Totowa, New Jersey facility from further production.

As if the Agency didn't have enough to contend with, today brought news of an extortion scam in which callers identify themselves as "FDA Special Agents" and pressure customers into buying drugs (which are never delivered) online.  Here's more from the source: